Home Autophagy-dependent ferroptosis in infectious disease
Article Open Access

Autophagy-dependent ferroptosis in infectious disease

  • Jiarou Li EMAIL logo and Hongliang Wang EMAIL logo
Published/Copyright: December 20, 2023

Abstract

Autophagy is the initial defense response of the host against pathogens. Autophagy can be either non-selective or selective. It selectively targets the degradation of autophagic substrates through the sorting and transportation of autophagic receptor proteins. However, excessive autophagy activity will trigger cell death especially ferroptosis, which was characterized by the accumulation of lipid peroxide and free iron. Several certain types of selective autophagy degrade antioxidant systems and ferritin. Here, we summarized the latest researches of autophagy in infection and discuss the regulatory mechanisms and signaling pathways of autophagy-dependent ferroptosis.

Introduction

Lysosomes have long been regarded as the “garbage-disposal system” for cells because of the more than 60 acid hydrolases.[1] Nevertheless, the function is more than breaking down cell components, foreign molecules, or pathogens[2]. In recent years, researchers have gained a better understanding of lysosomes by combining genomics, transcriptomics, proteomics, bioinformatics, and other methods. Lysosomes are now regarded as regulators of cell homeostasis that mediate signal transduction, metabolic adaptation, cell proliferation, the quality control of proteins and organelles, and even programmed cell death.[3, 4, 5] The process by which selected cellular components are transported to and broken down within lysosomes is called Macroautophagy. Macroautophagy is a physiological process that contributes to the high conservation of intracellular homeostasis. In addition, autophagy also occurs selectively. The soluble or membrane-binding receptors recognize cargo and mediate the formation of autophagosomes. The selective sequestration into autophagosomes depends on the interaction between the cargo-binding receptor and Autophagy-related protein 8 (ATG8) family proteins anchored on the membrane forming autophagosome. Excessive or dysfunctional autophagy and cellular killing are highly correlated.[6] In particular, the term “autophagy-dependent cell death” was recommended by the Nomenclature Committee on Cell Death to describe a form of ferroptosis-regulated cell death (RCD) that mechanistically depends on the autophagic machinery or components.[7] In this narrative review, we will discuss the latest evidence for the significant role of autophagy-mediated ferroptosis in infectious diseases.

Infection and inflammation initiate autophagy

At present, the diagnosis, treatment, and prevention of infectious diseases worldwide are still facing severe challenges.[8] Sepsis is the number one healthcare cost and cause of death in hospitals.[9] Shock and multi-organ failure from Sepsis may lead to adverse outcomes.[10]

Infection-induced autophagy is initiated by the binding of pathogen-associated molecular patterns within the microbial structure to pattern recognition receptors, such as toll-like receptors.[11, 12] This activates different intracellular events and leads to increased autophagic activity by promoting the conversion of microtubule-associated protein1 light chain 3-I to -II (LC3 to LC3-II) in turn.[13] As such, binding of lipopolysaccharides of Gram-negative pathogens onto toll–like receptor 4 (TLR4) activates autophagy via the p38/ Mitogen-Activated Protein Kinase (p38/MAPK) signaling axis whereas binding of lipoteichoic acid to TLR2 induces autophagy by the MAPK1/ERK2-MAPK3/ERK1 pathway. Different TLR ligands exhibit variable autophagyinducing abilities. Single-stranded RNA binding to TLR7 is the most efficient inducer.[11, 14]

Defense function of moderate autophagy

There are at least four general pathways that may be used for autophagy-protein-dependent targeting of bacteria to the lysosome. These include the autophagy-proteinfacilitated fusion of pathogen-containing phagosomes with lysosomes, the envelopment of bacteria-containing phagosomes or endosomes by autophagosomal membranes, the fusion of bacteria-containing phagosomes or endosomes with autophagosomes, or the xenophagic capture of bacteria that have escaped inside the cytoplasm.[15, 16] LC3 / ATG8 is cleaved by ATG4 at the carboxyl end to produce cytoplasmic LC3-1. LC3-1 is coupled with phosphatidylethanolamine (PE) through ATG7 and 3 (corresponding to E1 and E2-like enzymes respectively) to produce lipidized LC3, also known as LC3-l1, which can be attached to the membrane of autophagosome.[16, 17] It is the structural protein of autophagosomes.

Cellular cargo is commonly targeted to autophagosomes by interactions between a molecular tag (such as polyubiquitin), adaptor proteins such as p62 or neighbor of BRCA1 Gene 1 (NBR1) (which recognize these tags and contain an LC3-interacting region (LIR) characterized by a WXXL or WXXI motif), and LC3. These adaptor molecules can mediate the selective recognition and degradation of aggregates by autophagy by binding ubiquitin chains on aggregates and key protein LC3 on the autophagy membrane (Figure 1).

Figure 1 Known pathways involving the autophagy machinery by which viruses and bacteria was targeted to the lysosome. Cathepsin B (CTSB) can directly cleaves the lysosomal calcium channel mucolipin 1 / transient receptor potential mucolipin 1 (MCOLN1/TRPML1). The inactive transcription factor EB(TFEB) is unable to induce transcription of lysosomal and autophagyrelated genes.
Figure 1

Known pathways involving the autophagy machinery by which viruses and bacteria was targeted to the lysosome. Cathepsin B (CTSB) can directly cleaves the lysosomal calcium channel mucolipin 1 / transient receptor potential mucolipin 1 (MCOLN1/TRPML1). The inactive transcription factor EB(TFEB) is unable to induce transcription of lysosomal and autophagyrelated genes.

Cysteine cathepsin is an important driving element of lysosomal work. They also play an indispensable role in autophagy, antigen presentation, cell stress signaling, metabolism, and lysosome-dependent cell death. Here, cathepsin B (CTSB) regulates the bioavailability of lysosomes and autophagosomes and plays an essential role in maintaining a precise balance between protein synthesis and degradation in lysosomes.[18] Under steady conditions, CTSB cleaves calcium channel mucolipin 1 / transient receptor potential mucolipin 1 (MCOLN1/TRPML1) in the lysosomal membrane, maintains the low level of transcription factor EB (TFEB), and reduces the expression of lysosomal and autophagy-related genes. This regulation stabilizes the number of lysosomes and autophagosomes in cells. As a negative feedback regulator of lysosomal biogenesis and autophagy, CTSB is a potential target of various bacterial infections. Mice and macrophages lacking cathepsin B activity showed obvious resistance to the cytosolic pathogen Francisella novicida CTSB-knockout animals produced fewer pro-inflammatory cytokines and chemokines in the liver.[19] Moreover, F. novicida exploited the activity of CTSB, resulting in permissiveness to bacterial replication and increasing susceptibility to infection.

To summarise, CTSB provides an apical signal controlling the expression of lysosomal and autophagy-related proteins as a way of maintaining the population of lysosomes and autophagosomes within a cell (Figure 1).[20]

The master modulator Transcription factor EB (TFEB) promotes both autophagy and lysosomal biogenesis via upregulating relevant genes. Increasing shreds of evidence have linked TFEB and the Subsequent Lysosome biogenesis with pathogenetic mechanisms and control of sepsis. TFEB-dependent xenophagy and autophagylysosome pathway (ALP) is critical for antimicrobial defense and therapeutic applications of sepsis. TFEB-activating agents, such as trehalose,[21] bedaquiline,[22] and acacetin,[23] enhanced bactericidal activity when the body is infected by intracellular pathogens (e.g., Mycobacterium tuberculosis and Salmonella typhimurium). In summary, TFEB has been recognized as the pharmacological target of their potential in treating sepsis.[24]

However, if TFEB is directly used as a drug to treat sepsis, its safety and effectiveness are still unconvincing. Both the status of autophagy and the activity of TFEB are altered during the progression of sepsis. Therefore, time-dependent changes in the expression and activity of TFEB in sepsis are needed to be evaluated.

Excess autophagy trigger ferroptotic cell death

As the genes involved in NF-κB signaling, autophagy and lysosomal protein degradation were synchronously enriched in the model of septic.[25, 26] It is beginning to be recognized that Altered autophagy function results in maladaptive inflammation and more severe disease.[27] Autophagy has its physiological roles and too much or too little autophagy can both be harmful. Deficient autophagy may lead to acute infection and tissue aging while excessive autophagy could result in cytokine storm and even cell death. [15, 28]

Previous studies have demonstrated that autophagy is involved in the regulation of endothelial permeability during inflammation.[2931]Moreover, the production, processing, and secretion of cytokines, such as IL-1 also need the participation of autophagy.[25, 32] Based on this theoretical basis, many people hypothesize that autophagy may represent a potential therapeutic strategy for preventing excessive inflammation during sepsis. Experimental results indicate that inhibition of autophagy at either initiation stage by 3-MA or autophagosome and lysosome fusion stage by CQ after E. coli infection have several beneficial effects.[33] It has hinted that inhibition of autophagy (at either initiation stage or autophagosome and lysosome fusion stage) after E. coli infection have several beneficial effects. preventing the over-production of pro-inflammatory cytokines and the development of endothelial hyperpermeability in mice. Autophagy inhibitors did not weaken the ability of immune cells to clear bacteria.

The relationship between autophagy and inflammatory factors was firstly explored in yeast.[34] Autophagy can enhance the activation of caspase-1 through a type of ATG5-dependent non-classical pathway, promoting the activation of the inflammasome and thereby increasing the synthesis of IL-1β and IL-18. In the meantime, any pro-inflammatory factors cannot be decomposed through the ER into autophagy due to the lack of signal peptides. Instead, Autophagy promotes the migration of these proinflammatory factors to the cytoplasm and aggravates the inflammatory damage of tissues.

In a recent study lipopolysaccharide (LPS)-induced ARDS both cellular and animal model demonstrated that IL-1β in secretory autophagosomes participate (SAP) in the pathogenesis of ARDS by mediating the inflammatory response and lung injury and this mechanism is associated with ras-related protein Rab-8A (RAB8a). Accordingly, SAPs may serve as a novel marker, and RAB8a may be a potential therapeutic target in ARDS. [35]

Ferroptosis is a common phenomenon in infectious diseases

Iron is an essential nutrient for both humans and pathogenic microbes. After infection, it causes competition for metals between bacterial pathogens and hosts[36, 37]. Bacteria extract Fe3+ from tissues, body fluids, cells, and proteins by secreting siderophores, heme acquisition systems, transferrin or lactoferrin receptors, and ferric or ferrous iron transporters. In contrast, hosts resist bacteria by isolating Fe3+ in binding proteins and ferritin.[38]

So far, many different kinds of bacterial infections have been confirmed to be associated with the activation of ferroptosis. For example, the Gram-negative bacterium aeruginosa can oxidize AA-PE to 15-hydroperoxy-AA-PE (15-HOO-AA-PE), and lipid peroxidation triggers ferroptosis in human bronchial epithelial cells. This chronic airway inflammation eventually leads to cystic fibrosis.[3941] The ability of Pseudomonas aeruginosa isolates in patients with persistent lower respiratory tract infections to induce ferroptosis depends on the level and enzymatic activity of pLoxA.[39] This process can be blocked by baicalein (an ALOX inhibitor) and ferrostatin- 1 (a ferroptosis inhibitor). With the new sight into the pathogenic mechanism of PA, it has been demonstrated that PA degrades the glutathione peroxidase-4 (GPX4) defense by activating the lysosomal chaperone-mediated autophagy (CMA).[40]

Mycobacterium tuberculosis (Mtb) caused tuberculosis (TB) is the leading cause of death by a single infectious agent. Macrophage necrosis after infection is the main cause of bacterial spread and disseminated disease.[42] Mtbinduced macrophage necrosis is associated with reduced levels of glutathione and GPX4, along with increased free iron, lipid peroxidation, and mitochondrial superoxide, all of which are characteristic marks of ferroptosis.[43] Moreover, necrosis in infected macrophage cultures was well suppressed by ferrostatin-1, a well-characterized ferroptosis inhibitor.

Recently more and more studies reported that ferroptosis is involved in the pathological development in the mouse model of polymicrobial sepsis induced by cecal ligation and puncture. Significant and specific changes of ferroptosis related indexes were detected in Multiple Organ Dysfunction caused by sepsis, such as heart,[44, 45] liver,[46] lung,[39, 47] and kidney.[48, 49] The lack of GPX4, FSP1, DHOD, and other defense system pathways is the main pathogenesis of ferroptosis.[50, 51]

Interestingly, ferroptosis has also been proven to be an important factor in viral infectious diseases. Many kinds of viruses will interfere with iron uptake, directly use iron transporters to enter cells or damage the antioxidant response system, resulting in ferroptosis.[52] There is growing evidence showing that ferroptosis may be a key component of the process leading to Multiorgan Damage pulmonary and extrapulmonary manifestations in COVID-19.[52, 53] In 2020, Jacobs et al. Published an autopsy report of a 48-year-old male patient who died of COVID-19 despite extracorporeal life support,[54] RRT and maximum drug treatment. The myocardial and proximal tubules of the kidney tissue were examined for markers of ferroptosis. Are indicators representing the degree of lipid peroxidation during ferroptosis, and their immunohistochemical stain are positive. These results highlight ferroptosis is probable to contribute to COVID-19 cardiac damage and multiple organ failure detrimentally.

Current research shows that there are three proposed mechanisms of Ferroptosis after sars-cov-2 infection: Dysregulation of Iron Metabolism, GSH-GPX4 Axis, and ROS over Generation. Abnormal expression of various proteins related to iron metabolism can be found in patients with COVID- 19. The infection [55, 56] may cause the degradation of ferritin through “ferritinophagy”[53, 55] and triggers the increase in a labile iron pool that increases the production of lipid peroxidation and ROS via the Fenton reaction and, eventually, promotes ferroptosis. In addition to this way, sars-cov-2 can also overproduce ROS by combining the TOM70 at the surface of the mitochondria membrane and triggering NOX. Targeting intracellular defense response, SARS-CoV-2 significantly suppressed mRNA expression of GPX4,[56] DNA synthesis-related thioredoxin reductase, and endoplasmic reticulum-resident selenoproteins.

In clinic, biomarkers related to ferroptosis show a good function of predicting the prognosis of patients with sepsis. Ferritin is an indicator of total iron load, hence it showed a better association in long-term survival analysis.[57] High transferin saturation (TSAT) presented a substantial predictive value for both short and long-term survival in septic patients, whereas low transferrin levels were only significantly associated with short-term mortality.[51, 58]

Figure 2 The role of different types of selective autophagy in ferroptosis. (A) RAB7A-mediated lipophagy, and (C) SQSTM1-mediated clockophagy promote lipid peroxidation in ferroptosis (B) Chaperone-mediated autophagy (CMA) blocks lipid peroxidation by degrading ACSL4 and promotes lipid peroxidation by degrading GPX4 in ferroptosis (D) NCOA4-mediated ferritinophagy promotes iron accumulation.
Figure 2

The role of different types of selective autophagy in ferroptosis. (A) RAB7A-mediated lipophagy, and (C) SQSTM1-mediated clockophagy promote lipid peroxidation in ferroptosis (B) Chaperone-mediated autophagy (CMA) blocks lipid peroxidation by degrading ACSL4 and promotes lipid peroxidation by degrading GPX4 in ferroptosis (D) NCOA4-mediated ferritinophagy promotes iron accumulation.

Molecular mechanism of autophagy-dependent ferroptosis

In addition to inflammatory response, autophagy activation caused by infection also plays a multifaceted regulator of cell death. The recently discovered function of autophagy, especially selective types of autophagy (e.g., ferritinophagy, lipophagy, clockophagy, and chaperone-mediated autophagy), in driving cells towards ferroptosis motivated us to explore the functional interactions between metabolism, lysosome, and cell death (Figure 2).

NCOA4-mediated ferritinophagy

Ferritinophagy is the process of autophagic degradation of the iron-storage protein ferritin, which is critical for the regulation of cellular iron levels.[59] A quantitative proteomic assay has unveiled a role for nuclear receptor coactivator 4 (NCOA4) as a selective cargo receptor for ferritinophagy, which interacts with an arginine residue in the C terminal domain of FTH1, accounting for selective sequestration and degradation of ferritin and elevated Fe2+ bioavailability in the cytosol. This delivery via macroautophagy enables cells to use stored iron. Meanwhile, the increase of free iron level provides the possibility of ferroptosis.[60, 61]

The NCOA4-ferritin axis modulates intracellular iron homeostasis in accordance with cellular iron availability.[62, 63] In the LPS induced sepsis myocardial injury model, we can see that the protein changes of NCOA4 and ferritin are closely related in a time-dependent manner.[62] LPS promotes the expression of NCOA4 and interaction between ferritin, which eventually leads to ferroptosis. NCOA4-ferritinophagy also participated in the progress of periodontitis, an inflammatory disease mostly caused by Porphyromonas gingivalis. This gram-negative anaerobe triggered the activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase signaling pathway. Ferritinophagy, which comes from NCOA4 transcription, aggravated production of the ROS and inflammatory responses in PDLFS.[64]

These findings suggest NCOA4 mediates iron homeostasis and plays an important role in the pathogenesis of infectious diseases.

RAB7A related Lipophagy

The lipid droplet proteome fluctuates with changes in cellular metabolic status, thus influencing the composition of neutral lipids in organelles.[65, 66] Lipophagy, the autophagic digestion of lipid droplets, can release free fatty acids, which then serve as a fuel for mitochondrial beta-type oxidation. The process by which intracellular lipid droplets are selectively transported by autophagosomes for lysosomal decomposition. Lipophagy provides another potential pathway for regulating cellular lipid levels and therefore, the propensity to ferroptosis.[67] RAB7A, a cargo receptor for autophagic LD, degradation promotes RSL3-induced ferroptotic cell death in hepatocytes. Lipid droplet accumulation is increased at the early stage but decreased at the late stage of ferroptosis in mouse or human hepatocytes.[66] Importantly, either genetically enhancing TPD52-dependent lipid storage or blocking ATG5-and RAB7A-dependent lipid degradation prevents RSL3-induced lipid peroxidation and subsequent ferroptosis in vitro and in vivo.[67] These studies support an antioxidant role in stable lipid droplets in cell death.

Chaperone-mediated autophagy

GPX4 is an irreplaceable anti-oxidant enzyme in cells.[68] It can reduce lipid peroxidation and inhibit the process of ferroptosis. The decrease of GPX4 quantity or activity is the clear mechanism of ferroptosis.[69] With the constant deepening of research on ferroptosis, it is found that the degradation of GPX4 protein is a pivotal event.[63, 70, 71]

Chaperone-mediated autophagy (CMA) is a type of selective autophagy that uses molecular chaperones to deliver certain cytosolic proteins to lysosomes for degradation based on the recognition of KFERQ-like motif within the sequence of a protein. [70, 72] Heat shock protein family A (Hsp70) member 8 (HSPA8/HSC70), and HSP90 are major molecular chaperones responsible for the recognition and later degradation.[63, 70, 73] Moreover, HSP90 can increase the stability of lysosomal-associated membrane protein 2A (LAMP2A), a CMA receptor, to assist GPX4 degradation. These findings establish a model of the interrelationship between CMA and ferroptosis. However, the structural basis of GPX4 degradation needs to be explored.

Degradation of GPX4 protein by CMA seems to be a common response to various ferroptosis activators.[74–76] Moreover, CMA-induced ferroptosis can be observed in inflammatory models caused by different injury factors, such as aseptic inflammation caused by pancreatitis,[77] radiation,[78] and ischemia-reperfusion,[79] and infection we mentioned above[39, 40]. Under damage conditions, the host GPX4 defense was degraded by activating the lysosomal chaperone-mediated autophagy (CMA), and the autophagy inhibitor Baf-A1 significantly increased the level of GPX4 and alleviated injury.

However, the role of CMA in ferroptosis may not be as simple as expected. A recent article shows that the activation of CMA may also specifically degrade ACSL4, which contains six possible KFERQ-like motifs. A fatty acid-activating enzyme, long-chain fatty acyl-CoA synthetase 4 (ACSL4) participates in fatty acid metabolism and then contributes to the production of lipid peroxidation [80]. In early diabetic retinopathy, Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4, resulting in the accumulation of lipid peroxidation.

SQSTM1-dependent clockophagy

CMA contributes to the rhythmic removal of clock machinery proteins and to the circadian remodelling of a subset of the cellular proteome. It has been show that “clockophagy,” the selective degradation of the core circadian clock protein -Aryl hydrocarbon receptor nuclear translocator like protein (ARNTL) by autophagy, is critical for ferroptosis.[81, 82] ARNTL inhibits ferroptosis by repressing the Egl nine homolog 2 (Egln2), thus activating the prosurvival transcription factor hypoxia inducible factor-1 (HIF1A). Measures to prevent ARNTL degradation or inhibit Egln2 activation can destroy the stability of HIF1A and promote the ferroptosis of tumor cells.[82, 83] Sequestosome 1(SQSTM1) is a multifunctional cargo receptor implicated in the autophagic degradation of ubiquitinated substrates, including proteins and organelles. Mass spectrometric analysis showed that SQSTM1 was the interactor of ARNTL under normal conditions. In RSL3-induced ferroptosis, immunoprecipitation analysis showed increased SQSTM1-ARNTL interaction.[81]

Conclusions and perspectives

Cytokine storm and organ damage caused by infectious diseases are life-threatening problems that have plagued people for a long time. With an in-depth understanding of the pathogenic mechanism of infection, it is found that autophagy-mediated ferroptosis dominate in cell injury and death. Excessive activation of autophagy can lead to degradation of intracellular defense or beneficial components. Here, we discuss recent progress in molecular mechanisms of autophagy-mediated ferroptosis, providing insights into all the networks of relationships between lysosome, infection, and ferroptosis.

Funding statement: Heilongjiang Provincial Postdoctoral Science Foundation of China (LBH-Q19137); The National Key Research and Development Program of China (2021YFC2501800); Heilongjiang Province Science Fund for Distinguished Young Scholars (JQ2021H002)

  1. Conflicts of Interest

    The authors declare that there are no conflict of interests.

References

1 Appelqvist H, Wäster P, Kågedal K, Öllinger K. The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol 2013;5:214–26.10.1093/jmcb/mjt022Search in Google Scholar PubMed

2 Murrow L, Debnath J. Autophagy as a Stress-Response and Quality-Control Mechanism: Implications for Cell Injury and Human Disease. Annu Rev Pathol Mech Dis 2013;8:105–37.10.1146/annurev-pathol-020712-163918Search in Google Scholar PubMed PubMed Central

3 Yang C, Wang X. Lysosome biogenesis: Regulation and functions. J Cell Biol 2021;220:e202102001.10.1083/jcb.202102001Search in Google Scholar PubMed PubMed Central

4 Cao M, Luo X, Wu K, He X. Targeting lysosomes in human disease: from basic research to clinical applications. Signal Transduct Target Ther 2021;6:379.10.1038/s41392-021-00778-ySearch in Google Scholar PubMed PubMed Central

5 Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol 2020;66:89–100.10.1016/j.semcancer.2019.03.002Search in Google Scholar PubMed

6 Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-Dependent Ferroptosis: Machinery and Regulation. Cell Chem Biol 2020;27:420–35.10.1016/j.chembiol.2020.02.005Search in Google Scholar PubMed PubMed Central

7 Bialik S, Dasari SK, Kimchi A. Autophagy-dependent cell death – where, how and why a cell eats itself to death. J Cell Sci 2018;131:jcs215152.10.1242/jcs.215152Search in Google Scholar PubMed

8 Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020;395:200–11.10.1016/S0140-6736(19)32989-7Search in Google Scholar PubMed PubMed Central

9 Arefian H, Heublein S, Scherag A, Brunkhorst FM, Younis MZ, Moerer O, et al. Hospital-related cost of sepsis: A systematic review. J Infect 2017;74:107–17.10.1016/j.jinf.2016.11.006Search in Google Scholar PubMed

10 Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet 2018;392:75–87.10.1016/S0140-6736(18)30696-2Search in Google Scholar PubMed

11 Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J 2008;27:1110–21.10.1038/emboj.2008.31Search in Google Scholar PubMed PubMed Central

12 Mizushima N, Yoshimori T, Levine B. Methods in Mammalian Autophagy Research. Cell 2010;140:313–26.10.1016/j.cell.2010.01.028Search in Google Scholar PubMed PubMed Central

13 Oh JE, Lee HK. Modulation of Pathogen Recognition by Autophagy. Front Immunol 2012;3:44.10.3389/fimmu.2012.00044Search in Google Scholar PubMed PubMed Central

14 Ho J, Yu J, Wong SH, Zhang L, Liu X, Wong WT, et al. Autophagy in sepsis: Degradation into exhaustion? Autophagy 2016;12:1073–82.10.1080/15548627.2016.1179410Search in Google Scholar PubMed PubMed Central

15 Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469:323–35.10.1038/nature09782Search in Google Scholar PubMed PubMed Central

16 Schreiber A, Peter M. Substrate recognition in selective autophagy and the ubiquitin-proteasome system. Biochim Biophys Acta 2014;1843:163–81.10.1016/j.bbamcr.2013.03.019Search in Google Scholar PubMed

17 Zientara-Rytter K, Subramani S. The Roles of Ubiquitin-Binding Protein Shuttles in the Degradative Fate of Ubiquitinated Proteins in the Ubiquitin-Proteasome System and Autophagy. Cells 2019;8:40.10.3390/cells8010040Search in Google Scholar PubMed PubMed Central

18 Szulc-Dąbrowska L, Bossowska-Nowicka M, Struzik J, Toka FN. Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance? Front Cell Infect Microbiol 2020;10:601072.10.3389/fcimb.2020.601072Search in Google Scholar PubMed PubMed Central

19 Qi X, Man SM, Malireddi RKS, Karki R, Lupfer C, Gurung P, et al. Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection. J Exp Med 2016;213:2081–97.10.1084/jem.20151938Search in Google Scholar PubMed PubMed Central

20 Man SM, Kanneganti T-D. Regulation of lysosomal dynamics and autophagy by CTSB/cathepsin B. Autophagy 2016;12:2504–5.10.1080/15548627.2016.1239679Search in Google Scholar PubMed PubMed Central

21 Sharma V, Makhdoomi M, Singh L, Kumar P, Khan N, Singh S, et al. Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block. Autophagy 2021;17:476–95.10.1080/15548627.2020.1725374Search in Google Scholar PubMed PubMed Central

22 Giraud-Gatineau A, Coya JM, Maure A, Biton A, Thomson M, Bernard EM, et al. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection. Elife 2020;9:e55692.10.7554/eLife.55692Search in Google Scholar PubMed PubMed Central

23 Ammanathan V, Mishra P, Chavalmane AK, Muthusamy S, Jadhav V, Siddamadappa C, et al. Restriction of intracellular Salmonella replication by restoring TFEB-mediated xenophagy. Autophagy 2020;16:1584–97.10.1080/15548627.2019.1689770Search in Google Scholar PubMed PubMed Central

24 Liu X, Zheng X, Lu Y, Chen Q, Zheng J, Zhou H. TFEB Dependent Autophagy-Lysosomal Pathway: An Emerging Pharmacological Target in Sepsis. Front Pharmacol 2021;12:794298.10.3389/fphar.2021.794298Search in Google Scholar PubMed PubMed Central

25 Busch K, Kny M, Huang N, Klassert TE, Stock M, Hahn A, et al. Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy. J Cachexia Sarcopenia Muscle 2021;12:1653–68.10.1002/jcsm.12763Search in Google Scholar PubMed PubMed Central

26 Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017;2:17023.10.1038/sigtrans.2017.23Search in Google Scholar PubMed PubMed Central

27 Kimmey JM, Stallings CL. Bacterial Pathogens versus Autophagy: Implications for Therapeutic Interventions. Trends Mol Med 2016;22:1060–76.10.1016/j.molmed.2016.10.008Search in Google Scholar PubMed PubMed Central

28 Jin M, Zhang Y. Autophagy and Inflammatory Diseases. In 2020. p. 391–400.10.1007/978-981-15-4272-5_26Search in Google Scholar PubMed

29 Chen H-R, Chuang Y-C, Chao C-H, Yeh T-M. Macrophage migration inhibitory factor induces vascular leakage via autophagy. Biol Open 2015;4:244–52.10.1242/bio.201410322Search in Google Scholar PubMed PubMed Central

30 Feng X, Guan W, Zhao Y, Wang C, Song M, Yao Y, et al. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway. J Cell Physiol 2019;234:18994–9009.10.1002/jcp.28539Search in Google Scholar PubMed

31 Chao C-H, Chen H-R, Chuang Y-C, Yeh T-M. Macrophage Migration Inhibitory Factor-Induced Autophagy Contributes to Thrombin-Triggered Endothelial Hyperpermeability in Sepsis. Shock 2018;50:103–11.10.1097/SHK.0000000000000976Search in Google Scholar PubMed

32 Harris J. Autophagy and IL-1 Family Cytokines. Front Immunol 2013;4:83.10.3389/fimmu.2013.00083Search in Google Scholar PubMed PubMed Central

33 Lu LH, Chao CH, Yeh TM. Inhibition of autophagy protects against sepsis by concurrently attenuating the cytokine storm and vascular leakage. J Infect 2019;78:178–86.10.1016/j.jinf.2018.12.003Search in Google Scholar PubMed

34 Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J 2011;30:4701–11.10.1038/emboj.2011.398Search in Google Scholar PubMed PubMed Central

35 Xu X, Liu X, Dong X, Qiu H, Yang Y, Liu L. Secretory Autophagosomes from Alveolar Macrophages Exacerbate Acute Respiratory Distress Syndrome by Releasing IL-1β. J Inflamm Res 2022;15:127–40.10.2147/JIR.S344857Search in Google Scholar PubMed PubMed Central

36 Cassat JE, Skaar EP. Iron in Infection and Immunity. Cell Host Microbe 2013;13:509–19.10.1016/j.chom.2013.04.010Search in Google Scholar PubMed PubMed Central

37 Nairz M, Weiss G. Iron in infection and immunity. Mol Aspects Med 2020;75:100864.10.1016/j.mam.2020.100864Search in Google Scholar PubMed

38 Klebba PE, Newton SMC, Six DA, Kumar A, Yang T, Nairn BL, et al. Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics. Chem Rev 2021;121:5193–239.10.1021/acs.chemrev.0c01005Search in Google Scholar PubMed PubMed Central

39 Dar HH, Tyurina YY, Mikulska-Ruminska K, Shrivastava I, Ting H-C, Tyurin VA, et al. Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium. J Clin Invest 2018;128:4639–53.10.1172/JCI99490Search in Google Scholar PubMed PubMed Central

40 Dar HH, Anthonymuthu TS, Ponomareva LA, Souryavong AB, Shurin GV, Kapralov AO, et al. A new thiol-independent mechanism of epithelial host defense against Pseudomonas aeruginosa: iNOS/NO• sabotage of theft-ferroptosis. Redox Biol 2021;45:102045.10.1016/j.redox.2021.102045Search in Google Scholar PubMed PubMed Central

41 Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, et al. Pseudomonas aeruginosa Microevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence. Am J Respir Crit Care Med 2009;180:138–45.10.1164/rccm.200812-1943OCSearch in Google Scholar PubMed

42 Amaral EP, Lasunskaia EB, D’Império-Lima MR. Innate immunity in tuberculosis: how the sensing of mycobacteria and tissue damage modulates macrophage death. Microbes Infect 2016;18:11–20.10.1016/j.micinf.2015.09.005Search in Google Scholar PubMed

43 Amaral EP, Costa DL, Namasivayam S, Riteau N, Kamenyeva O, Mittereder L, et al. A major role for ferroptosis in Mycobacterium tuberculosis–induced cell death and tissue necrosis. J Exp Med 2019;216:556–70.10.1084/jem.20181776Search in Google Scholar PubMed PubMed Central

44 Kong C, Ni X, Wang Y, Zhang A, Zhang Y, Lin F, et al. ICA69 aggravates ferroptosis causing septic cardiac dysfunction via STING trafficking. Cell Death Discov 2022;8:187.10.1038/s41420-022-00957-ySearch in Google Scholar PubMed PubMed Central

45 Wang N, Ma H, Li J, Meng C, Zou J, Wang H, et al. HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J Mol Cell Cardiol 2021;150:65–76.10.1016/j.yjmcc.2020.10.010Search in Google Scholar PubMed

46 Wei S, Bi J, Yang L, Zhang J, Wan Y, Chen X, et al. Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice. Clin Transl Med 2020;10:e173.10.1002/ctm2.173Search in Google Scholar PubMed PubMed Central

47 Yin X, Zhu G, Wang Q, Fu YD, Wang J, Xu B. Ferroptosis, a New Insight Into Acute Lung Injury. Front Pharmacol 2021;12:709538.10.3389/fphar.2021.709538Search in Google Scholar PubMed PubMed Central

48 Xiao J, Yang Q, Zhang Y, Xu H, Ye Y, Li L, et al. Maresin conjugates in tissue regeneration-1 suppresses ferroptosis in septic acute kidney injury. Cell Biosci 2021;11:221.10.1186/s13578-021-00734-xSearch in Google Scholar PubMed PubMed Central

49 Liang NN, Zhao Y, Guo YY, Zhang ZH, Gao L, Yu DX, et al. Mitochondria-derived reactive oxygen species are involved in renal cell ferroptosis during lipopolysaccharide-induced acute kidney injury. Int Immunopharmacol 2022;107:108687.10.1016/j.intimp.2022.108687Search in Google Scholar PubMed

50 Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, et al. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxid Med Cell Longev 2019;2019:1–13.10.1155/2019/5080843Search in Google Scholar PubMed PubMed Central

51 Liu Q, Wu J, Zhang X, Wu X, Zhao Y, Ren J. Iron homeostasis and disorders revisited in the sepsis. Free Radic Biol Med 2021;165:1–13.10.1016/j.freeradbiomed.2021.01.025Search in Google Scholar PubMed

52 Wang M, Joshua B, Jin N, Du S, Li C. Ferroptosis in viral infection: the unexplored possibility. Acta Pharmacol Sin 2022;43:1905–15.10.1038/s41401-021-00814-1Search in Google Scholar PubMed PubMed Central

53 Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID- 19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother 2021;136:111228.10.1016/j.biopha.2021.111228Search in Google Scholar PubMed PubMed Central

54 Jacobs W, Lammens M, Kerckhofs A, Voets E, Van San E, Van Coillie S, et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID‐19): autopsy reveals a ferroptosis signature. ESC Hear Fail 2020;7:3772–81.10.1002/ehf2.12958Search in Google Scholar PubMed PubMed Central

55 Jia F, Liu H, Kang S. NCOA4-Mediated Ferritinophagy: A Vicious Culprit in COVID-19 Pathogenesis? Front Mol Biosci 2021;8:761793.10.3389/fmolb.2021.761793Search in Google Scholar PubMed PubMed Central

56 Wang Y, Huang J, Sun Y, Stubbs D, He J, Li W, et al. SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis. Food Chem Toxicol 2021;153:112286.10.1016/j.fct.2021.112286Search in Google Scholar PubMed PubMed Central

57 Siddique A, Kowdley K V. Review article: the iron overload syndromes. Aliment Pharmacol Ther 2012;35:876–93.10.1111/j.1365-2036.2012.05051.xSearch in Google Scholar PubMed

58 Brandtner A, Tymoszuk P, Nairz M, Lehner GF, Fritsche G, Vales A, et al. Linkage of alterations in systemic iron homeostasis to patients’ outcome in sepsis: a prospective study. J Intensive Care 2020;8:76.10.1186/s40560-020-00495-8Search in Google Scholar PubMed PubMed Central

59 Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, et al. Ferritinophagymediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med 2020;160:303–18.10.1016/j.freeradbiomed.2020.08.009Search in Google Scholar PubMed

60 Mancias JD, Pontano Vaites L, Nissim S, Biancur DE, Kim AJ, Wang X, et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife 2015;4:e10308.10.7554/eLife.10308Search in Google Scholar PubMed PubMed Central

61 Santana-Codina N, Gikandi A, Mancias JD. The Role of NCOA4-Mediated in. In 2021. p. 41–57.10.1007/978-3-030-62026-4_4Search in Google Scholar PubMed

62 Ryu MS, Duck KA, Philpott CC. Ferritin iron regulators, PCBP1 and NCOA4, respond to cellular iron status in developing red cells. Blood Cells Mol Dis 2018;69:75–81.10.1016/j.bcmd.2017.09.009Search in Google Scholar PubMed PubMed Central

63 Chen C, Wang D, Yu Y, Zhao T, Min N, Wu Y, et al. Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI. Cell Death Dis 2021;12:65.10.1038/s41419-020-03362-4Search in Google Scholar PubMed PubMed Central

64 Guo W, Zhao Y, Li H, Lei L. NCOA4‐mediated ferritinophagy promoted inflammatory responses in periodontitis. J Periodontal Res 2021;56:523–34.10.1111/jre.12852Search in Google Scholar PubMed

65 Liu K, Czaja MJ. Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ 2013;20:3–11.10.1038/cdd.2012.63Search in Google Scholar PubMed PubMed Central

66 Zhang S, Peng X, Yang S, Li X, Huang M, Wei S, et al. The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders. Cell Death Dis 2022;13:132.10.1038/s41419-022-04593-3Search in Google Scholar PubMed PubMed Central

67 Bai Y, Meng L, Han L, Jia Y, Zhao Y, Gao H, et al. Lipid storage and lipophagy regulates ferroptosis. Biochem Biophys Res Commun 2019;508:997–1003.10.1016/j.bbrc.2018.12.039Search in Google Scholar PubMed

68 Maiorino M, Conrad M, Ursini F. GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues. Antioxid Redox Signal 2018;29:61–74.10.1089/ars.2017.7115Search in Google Scholar PubMed

69 Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med 2019;133:144–52.10.1016/j.freeradbiomed.2018.09.014Search in Google Scholar PubMed

70 Wu Z, Geng Y, Lu X, Shi Y, Wu G, Zhang M, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci U S A 2019;116:2996–3005.10.1073/pnas.1819728116Search in Google Scholar PubMed PubMed Central

71 Thayyullathil F, Cheratta AR, Alakkal A, Subburayan K, Pallichankandy S, Hannun YA, et al. Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis. Cell Death Dis 2021;12:26.10.1038/s41419-020-03297-wSearch in Google Scholar PubMed PubMed Central

72 Li W, Nie T, Xu H, Yang J, Yang Q, Mao Z. Chaperone-mediated autophagy: Advances from bench to bedside. Neurobiol Dis 2019;122:41–8.10.1016/j.nbd.2018.05.010Search in Google Scholar PubMed

73 Liu Y, Zhou L, Xu Y, Li K, Zhao Y, Qiao H, et al. Heat Shock Proteins and Ferroptosis. Front Cell Dev Biol 2022;10:864635.10.3389/fcell.2022.864635Search in Google Scholar PubMed PubMed Central

74 Müller T, Dewitz C, Schmitz J, Schröder AS, Bräsen JH, Stockwell BR, et al. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cell Mol Life Sci 2017;74:3631–45.10.1007/s00018-017-2547-4Search in Google Scholar PubMed PubMed Central

75 Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol 2016;12:497–503.10.1038/nchembio.2079Search in Google Scholar PubMed PubMed Central

76 Zhu S, Zhang Q, Sun X, Zeh HJ, Lotze MT, Kang R, et al. HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells. Cancer Res 2017;77:2064–77.10.1158/0008-5472.CAN-16-1979Search in Google Scholar PubMed PubMed Central

77 Liu K, Liu J, Zou B, Li C, Zeh HJ, Kang R, et al. Trypsin-Mediated Sensitization to Ferroptosis Increases the Severity of Pancreatitis in Mice. Cell Mol Gastroenterol Hepatol 2022;13:483–500.10.1016/j.jcmgh.2021.09.008Search in Google Scholar PubMed PubMed Central

78 Li L, Wu D, Deng S, Li J, Zhang F, Zou Y, et al. NVP-AUY922 alleviates radiation-induced lung injury via inhibition of autophagy-dependent ferroptosis. Cell Death Discov 2022;8:86.10.1038/s41420-022-00887-9Search in Google Scholar PubMed PubMed Central

79 Lin JH, Yang KT, Lee WS, Ting PC, Luo YP, Lin DJ, et al. Xanthohumol Protects the Rat Myocardium against Ischemia/Reperfusion Injury-Induced Ferroptosis. Oxid Med Cell Longev 2022;2022:9523491.10.1155/2022/9523491Search in Google Scholar PubMed PubMed Central

80 Liu C, Sun W, Zhu T, Shi S, Zhang J, Wang J, et al. Glia maturation factor-β induces ferroptosis by impairing chaperone-mediated autophagic degradation of ACSL4 in early diabetic retinopathy. Redox Biol 2022;52:102292.10.1016/j.redox.2022.102292Search in Google Scholar PubMed PubMed Central

81 Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, et al. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv 2019;5:eaaw2238.10.1126/sciadv.aaw2238Search in Google Scholar PubMed PubMed Central

82 Juste YR, Kaushik S, Bourdenx M, Aflakpui R, Bandyopadhyay S, Garcia F, et al. Reciprocal regulation of chaperone-mediated autophagy and the circadian clock. Nat Cell Biol 2021;23:1255–70.10.1038/s41556-021-00800-zSearch in Google Scholar PubMed PubMed Central

83 Liu J, Yang M, Kang R, Klionsky DJ, Tang D. Autophagic degradation of the circadian clock regulator promotes ferroptosis. Autophagy 2019;15:2033–5.10.1080/15548627.2019.1659623Search in Google Scholar PubMed PubMed Central

Published Online: 2023-12-20

© 2023 Jiarou Li, Hongliang Wang, published by De Gruyter on behalf of Scholar Media Publishing

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Perspective
  2. Mucus hypersecretion in chronic obstructive pulmonary disease: From molecular mechanisms to treatment
  3. Timing of TIPS for the management of portal vein thrombosis in liver cirrhosis
  4. Commentary
  5. Could unpublishing negative results be harmful to the general public?
  6. Review Article
  7. Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
  8. Mitochondrial damage-associated molecular patterns in chronic obstructive pulmonary disease: Pathogenetic mechanism and therapeutic target
  9. Exosomes and their derivatives as biomarkers and therapeutic delivery agents for cardiovascular diseases: Situations and challenges
  10. Autophagy-dependent ferroptosis in infectious disease
  11. Impact of gut microbiota and associated mechanisms on postprandial glucose levels in patients with diabetes
  12. Circular RNA: A promising new star of vaccine
  13. Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease
  14. Original Article
  15. Hypervolemia suppresses dilutional anaemic injury in a rat model of haemodilution
  16. Prognostic value of serum ammonia in critical patients with non-hepatic disease: A prospective, observational, multicenter study
  17. Global lineage evolution pattern of sars-cov-2 in Africa, America, Europe, and Asia: A comparative analysis of variant clusters and their relevance across continents
  18. Efficacy and safety of QL0911 in adult patients with chronic primary immune thrombocytopenia: A multicenter, randomized, double-blind, placebo-controlled, phase III trial
  19. A pan-cancer analysis of the oncogenic role of Golgi transport 1B in human tumors
  20. Short-term duration of diabetic retinopathy as a predictor for development of diabetic kidney disease
  21. Cardiac magnetic resonance imaging-derived septum swing index detects pulmonary hypertension: A diagnostic study
  22. Letter to Editor
  23. Temporal trend of acute myocardial infarction-related mortality and associated racial/ethnic disparities during the omicron outbreak
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.2478/jtim-2023-0099/html
Scroll to top button